Emergence of catalytic bioscavengers against organophosphorus agents by Masson P. & Lushchekina S.
Emergence of catalytic bioscavengers against organophosphorus
agents
Patrick Masson a, *, Sofya V. Lushchekina b
a Neuropharmacology Laboratory, Kazan Federal University, 18 Kremlevskaia St., 48000 Kazan, Russian Federation
b Emanuel Institute of Biophysical Physics of Russian Academy of Sciences, Moscow, Russian Federation
a r t i c l e i n f o
Article history:
Received 14 November 2015
Received in revised form
16 December 2015
Accepted 10 February 2016
Available online 17 February 2016
Keywords:
Biopharmaceutical
Bioscavenger
Cholinesterase
Nerve agent
Organophosphorus compound
Paraoxonase
Phosphotriesterase
a b s t r a c t
Bioscavengers are an effective alternative approach for pre- and post-exposure treatments of nerve agent
(NA) poisoning. Bioscavengers are natural or recombinant enzymes, reactive proteins, and antibodies
that neutralize NAs before they reach their physiological targets. They are administered by injection
(protein or gene delivery vector) and react with NAs in the bloodstream. Other ways of delivery can be
used: inhalation for pulmonary delivery, topical creams for skin protection, etc. Operational bio-
scavengers must be producible at low cost, not susceptible to induce immune response and adverse
effects, and stable in the bloodstream, upon storage, and under ﬁeld conditions.
First generation bioscavengers, cholinesterases and carboxylesterases, are stoichiometric bio-
scavengers. However, stoichiometric neutralization of NAs needs administration of huge doses of costly
biopharmaceuticals. Second generation bioscavengers are catalytic bioscavengers. These are capable of
detoxifying organophosphates regeneratively. By virtue of high turnover, much lower doses are needed
for rapid neutralization of toxicants. The most promising catalytic bioscavengers are evolved mutants of
phosphotriesterases (bacterial enzymes, mammalian paraoxonases), displaying enantiomeric preference
for toxic NA isomers. However, engineering of cholinesterases, carboxylesterases, prolidases and other
enzymes, e.g. phosphotriesterases-lactonases from extremophiles is of interest. In particular, association
of cholinesterase mutants (not susceptible to age after phosphylation) with fast-reactivating oximes
leads to pseudocatalytic bioscavengers. Thus, catalytic and pseudocatalytic bioscavengers are an
improvement of bioscavenger-based medical countermeasures in terms of efﬁcacy and cost.
© 2016 Elsevier Ireland Ltd. All rights reserved.
1. Introduction
Bioscavengers are enzymes, antibodies, and reactive proteins,
that sequester and inactivate highly toxic compounds before these
molecules reach their biological targets. The idea that exogenous
bioscavengers could be used for protection against NAs and treat-
ment of poisoning was introduced some 30 years ago [1]. In fact, it
was known for decades that endogenous enzymes react with OPs in
the body and exert some protection against OP poisoning [2]. It was
also known that numerous enzymes degrade and detoxify OPs,
including nerve agents (NAs) [3,4].
We must consider three types of bioscavengers: 1) stoichio-
metric bioscavengers that neutralize OPs in a mole-to-mole reac-
tion; 2) pseudocatalytic bioscavengers, which are stoichiometric
bioscavengers that are continuously regenerated after phosphyla-
tion in a coupled nucleophile-mediated reaction, and 3) catalytic
bioscavengers for which OPs are substrates.
First studies on exogenous bioscavengers demonstrated the
protective effect of stoichiometric bioscavengers [1] and catalytic
bioscavengers [5]). In the past 20 years, research was dominated by
the development of ﬁrst generation bioscavengers, mostly human
butyrylcholinesterase (BChE) as an alternative to pharmacological
drugs for pre-treatment of NA poisoning [6] and post-exposure
treatment [7]. However, the trend is being reversed. Several
recent reviews pointed out the interest of catalytic bioscavengers
[8e11]. Moreover, during the joint international conference on
cholinesterases and paraoxonases there were twice as many com-
munications about catalytic bioscavengers than about stoichio-
metric bioscavengers (http://tox.umh.es/12thche/index.html). The
present article illustrates the advantages of catalytic bioscavengers
Abbreviations: AChE, acetylcholinesterase; BChE, butyrylcholinesterase; CaE,
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